Description
+ Include: 36 videos + 1 pdf, size: 16.3 GB
+ Target Audience: oncologists
+ Sample video: contact me for sample video
+ Information:
The 18th St. Gallen International Breast Cancer Conference 2023 took place from March 15-18, 2023, at the Austria Center Vienna. This conference brought together experts and major breast cancer cooperative groups and centers worldwide to present and critically review the latest data in breast cancer research and clinical management
Key topics included:
- Theragnostic biomarkers of breast cancer.
- Surgery and radiation therapy for early breast cancer.
- Systemic treatments and translational research priorities.
- Survivorship, patient-reported outcomes, and quality of life.
- Genomics, transcriptomics, and ctDNA for disease monitoring and risk stratification.
- Immunotherapy and the tumor microenvironment.
- Innovations in clinical trials and treatment options
The conference also featured a virtual platform for those unable to attend in person, with live streaming of all sessions and access to a virtual exhibition
+ Topics:
Adequate treatment for early breast cancer in LMIC.mp4
Agenda.pdf
Breast Surgery Standards in 2023.mp4
CDK46 Inhibition in early breast cancer – who benefits.mp4
Chemotherapy in early breast cancer – who benefits.mp4
Debate I Early breast cancer do we need chemotherapy in low genomic high clinical risk (ER+ HER2-).mp4
Debate II Axillary dissection versus axillary radiation for residual nodal disease after neoadjuvant systemic therapy.mp4
Debate III If you achieve pCR after neoadjuvant, do you need adjuvant therapy.mp4
Debate IV Surgery of the primary for stage IV disease.mp4
Early Detection, Diagnosis of Breast Cancer, quality control and Public Health Aspects.mp4
Endocrine therapies in early breast cancer.mp4
Gene signatures – who benefits.mp4
Immunotherapy for early breast cancer – who benefits.mp4
Interactive Session I How to avoid unnecessary mastectomies – a global discussion.mp4
Interactive Session II Too big, too small Too low, too high Adjuvant choices when stage and biology do not align..mp4
Interactive Session III Controversies and uncertainties in axillary management.mp4
Luminal B-like cancers and neoadjuvant systemic therapy – who benefits.mp4
Modern radiotherapy for early breast cancer.mp4
New drugs on the horizon for early breast cancer.mp4
Opening Ceremony Welcome, Awards and Award Lectures.mp4
Overtreatment in early breast cancer – who is at risk.mp4
Preop MRI helpful or dangerous for the breast surgeon.mp4
Session 1 News in breast cancer care since St. Gallen 2021 Best Poster Awards 2023.mp4
Session 10 Global Prespective on breast cancer treatment.mp4
Session 11 Optimizing treatment in patients with HR positive breast cancer.mp4
Session 2 Genomics, Transcriptomics, ctDNA for disease monitoring and risk stratification.mp4
Session 3 Immunology in early breast cancer.mp4
Session 4 Hereditary Breast Cancer.mp4
Session 5 The future treatment landscape in the adjuvant setting.mp4
Session 6 Tailoring breast surgery and radiotherapy.mp4
Session 7 Controversies in the treatment of the axilla.mp4
Session 8 Optimizing treatment in patients with HER2-positive breast cancer.mp4
Session 9 Optimizing treatment in patients with triple negative breast cancer.mp4
Special lecture I and panel discussion.mp4
Systemic therapy in older persons for early breast cancer.mp4
The importance of defining standards of care for breast cancer.mp4
The Rise of CDK46 Inhibitors in HR+HER2- Early Breast Cancer Impact For Patients.mp4
Reviews
There are no reviews yet.